These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9475837)

  • 1. Novel cost-effective approaches to the treatment of community-acquired infections.
    Schwarzmann SW
    Ann Pharmacother; 1998 Jan; 32(1):S27-30. PubMed ID: 9475837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010].
    Wang H; Liu YL; Chen MJ; Xu YC; Sun HL; Yang QW; Hu YJ; Cao B; Chu YZ; Liu Y; Zhang R; Yu YS; Sun ZY; Zhuo C; Ni YX; Hu BJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):113-9. PubMed ID: 22455967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.
    Jacobs MR; Felmingham D; Appelbaum PC; Grüneberg RN;
    J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods.
    Morrissey I; Robbins M; Viljoen L; Brown DF
    J Antimicrob Chemother; 2005 Feb; 55(2):200-8. PubMed ID: 15649996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
    Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
    Melo-Cristino J; Fernandes ML; Serrano N;
    Acta Med Port; 2001; 14(5-6):459-68. PubMed ID: 11878155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory tract infection: epidemiology and surveillance.
    Jacobs MR
    J Chemother; 1997 May; 9 Suppl 3():10-7. PubMed ID: 9248976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of resistance in bacteria causing community-acquired respiratory tract infections.
    Felmingham D; Feldman C; Hryniewicz W; Klugman K; Kohno S; Low DE; Mendes C; Rodloff AC
    Clin Microbiol Infect; 2002; 8 Suppl 2():12-42. PubMed ID: 12427206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter study of the antimicrobial susceptibility of Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis isolated from patients with community-acquired lower respiratory tract infections in 1999 in Portugal.
    Melo-Cristino J; Fernandes ML; Serrano N;
    Microb Drug Resist; 2001; 7(1):33-8. PubMed ID: 11310801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
    Pfaller MA; Farrell DJ; Sader HS; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with appropriate antibiotic therapy in community-acquired respiratory tract infections.
    Nicolau DP
    Am J Manag Care; 2004 Oct; 10(12 Suppl):S381-8. PubMed ID: 15603247
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical implications of resistance in the management of respiratory tract infections.
    Garau J
    Can Respir J; 1999; 6 Suppl A():23A-6A. PubMed ID: 10202229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
    Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT
    J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007].
    Sun HL; Yang QW; Xu YC; Wang H; Xie XL; Chen MJ; Zhang XZ; Liu Y; Ye HF; Sun ZY; Duan Q; Ni YX; Yu YS; Zhao WS; He L; Wang J; Ji P; Liu PP; Zhang LX
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2983-7. PubMed ID: 20137709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin.
    Felmingham D
    J Infect; 2002 Feb; 44 Suppl A():3-10. PubMed ID: 12150493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of antimicrobial resistance in community-acquired pulmonary pathogens.
    Cunha BA; Shea KW
    Semin Respir Infect; 1998 Mar; 13(1):43-53. PubMed ID: 9543475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical relevance of in-vitro resistance to penicillin, ampicillin, amoxycillin and alternative agents, for the treatment of community-acquired pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
    Klugman KP
    J Antimicrob Chemother; 1996 Jul; 38 Suppl A():133-40. PubMed ID: 8858479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens--findings of the Alexander Project 1992-1996.
    Felmingham D; Washington J
    J Chemother; 1999 Feb; 11 Suppl 1():5-21. PubMed ID: 10207769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-acquired upper respiratory tract infections and the role of third-generation oral cephalosporins.
    Hedrick JA
    Expert Rev Anti Infect Ther; 2010 Jan; 8(1):15-21. PubMed ID: 20014898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.